160324-f-hc995-002

Scottish Medicines Consortium enables access to treatment for rare inherited bone disorder in children

February 18, 2020
Manufacturing and Production Crysvita, Kyowa Kirin, SMC, Scottish Medicine Consortium, nhs scotland

The Scottish Medicines Consortium (SMC) has enabled access to Kyowa Kirin’s Crysvita (burosumab) for the NHS in Scotland to treat …

Novartis’ Beovu approved in Europe after outclassing Eylea in wet age-related macular degeneration

February 18, 2020
Manufacturing and Production, Sales and Marketing Beovu, Eylea, Novartis, Regeneron, macular degeneration, pharma

The European Commission (EC) has chosen to approve Novartis’ Beovu (brolucizumab) injection, it has emerged, as a treatment for wet …

merck-keytruda-pembrolizumab-melanoma

NICE gives initial ‘no’ to NHS England for kidney cancer drug

February 18, 2020
Manufacturing and Production NHS England, NICE, clinical trials, inlyta, keytruda

The National Institute for Health and Care Excellence (NICE) has not recommended Keytruda (pembrolizumab) and Inlyta (axitinib) for the treatment …

syringe-and-hypodermic-needles

Rapid testing to help combat worst UK outbreak of HIV in 30 years

February 18, 2020
Manufacturing and Production AIDS, HIV, HIV England, HIV Scotland, HIV epidemic, HIV/AIDS

New HIV tests that provide results in minutes are being used in Glasgow to fight a recent outbreak of HIV. …

Patient Experience: Living with multiple rare diseases

February 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, pharma, rare disease

Carole Scrafton discusses her experience living with Ehlers-Danlos syndrome alongside other rare conditions that have manifested throughout her life, and …

19199400883_6db786ce0d_b

Lawsuit against FDA claims Bernie Sanders played role in approval of rival drug

February 17, 2020
Research and Development, Sales and Marketing Bernie, Bernie Sanders, Catalyst Pharmaceuticals, FDA, TRUMP FDA, US FDA

Catalyst Pharmaceutical is attempting to show in court that pressure from US Senator Bernie Sanders led to the approval of …

eisa0008_web

Eisai releases new Phase 2 data for levatinib+everolimus combo in advanced kidney cancer

February 17, 2020
Research and Development, Sales and Marketing Cancer, Eisai, Kidney cancer, Lenvima, pharma, renal cell carcinoma

New Phase 2 data has been revealed for Eisai’s Lenvima (levatinib), delivered alongside Novartis’ everolimus, for the treatment of unresectable …

entrance_takeda_i020_v1

Strong Phase 3 data for Takeda’s subcutaneous Entyvio in moderate to severe Crohn’s disease

February 17, 2020
Research and Development, Sales and Marketing Crohn’s disease, Entyvio, Takeda, crohn's disease, pharma

Takeda has shared positive new Phase 3 data on a subcutaneous formulation of its gut-selective biologic Entyvio (vedolizumab) as a …

4829288798_876971e5d4_b

Experts call on NICE to recommended a ban on OTC codeine sales

February 17, 2020
Research and Development, Sales and Marketing Codein, NICE, opioid crisis, opioids, prescription drugs

Experts have called for a ban on the sale of over the counter codeine as NICE is set to publish …

money-1811937_960_720

India considering export restrictions on antibiotics due to coronavirus

February 17, 2020
Sales and Marketing Chinese Coronavirus, Indian Pharma, Wuhan, china coronavirus, coronavirus, drugs

The Indian government is considering an export ban on antibiotics, vitamins and hormones due to the lockdown of Hubei province, …

top_10_image_2_1_0

Top Ten most popular articles on Pharmafile.com this week

February 14, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, Chinese Coronavirus, Wuhan, Wuhan Coronavirus, china coronavirus, coronavirus

The coronavirus continues to dominate the news, with the disease finally getting treated. In America, a patient has been successfully …

vaccination-1215279_960_720

Mumps cases in England rocket four-fold to highest point in a decade

February 14, 2020
Medical Communications, Research and Development MMR vaccine, Vaccine, anti-vaccine, pharma

The incidence of mumps in the England has reached its highest level in 10 years, prompting warnings from health officials …

6127243966_e9189f1099_b

Global drug market’s production line threatened by coronavirus

February 14, 2020
Medical Communications Chinese Coronavirus, Drug markets, Wuhan Coronavirus, china epidemic, coronavirus, drugs, epidemic, pharma

The global drug market is facing issues over production due to the coronavirus ravaging the supply line from China. In …

eisa0008_web

Eisai withdraws weight loss drug Belviq after FDA highlights cancer risk

February 14, 2020
Medical Communications, Research and Development, Sales and Marketing Belviq, Eisai, FDA, pharma

The FDA has requested that Eisai withdraw its weight loss drug Belviq (lorcaserin) and Belviq XR from the US market …

Insulin pumps tied to over 2,000 injuries recalled

February 14, 2020
Medical Communications Type 1 diabetes, diabetes, insulin, type 1, type 2, type 2 diabetes

Over 300,000 insulin pumps have been recalled by Medtronic after injuries and one death were reported due to devices malfunctioning. …

Sanofi axes four major players from its executive committee

February 13, 2020
Manufacturing and Production, Medical Communications Sanofi, appointments, pharma

Sanofi has announced it will cull its executive committee under plans orchestrated by new Chief Executive Officer Paul Hudson, who …

shutterstock_159488225

Lilly and Incyte’s atopic dermatitis drug shows promise at Phase 3

February 13, 2020
Sales and Marketing Eli Lilly, Incyte, baricitinib, pharma

Eli Lilly and Incyte have pulled back the curtain on Phase 3 data on their oral selective JAK inhibitor baricitinib …

unnamed

Forecasts show branded generics will double in revenue with Asia driving growth

February 13, 2020
Business Services branded drugs, drug patents, patents

Branded generic drugs are expected to grow in global sales by 8% by 2029, but Europe and America will not …

citizens_of_wuhan_lining_up_outside_of_a_drug_store_to_buy_masks_during_the_wuhan_coronavirus_outbreak

Highest fatalities from coronavirus recorded in a single day due to new classifications

February 13, 2020
Business Services China, UK Coronavirus, Wuhan, Wuhan Coronavirus, coronavirus

The coronavirus outbreak reached its deadliest day since it began in December. Roughly 242 deaths have been reported in Hubei …

190509-f-jf989-059

NICE does not recommend cancer drug combination to the NHS

February 13, 2020
Business Services Cancer, Kidney cancer, NHS, NICE, keytruda, kidney disease

NICE has published draft guidance that does not recommend a new drug combination to combat untreated advanced renal cell carcinoma …

The Gateway to Local Adoption Series

Latest content